Literature DB >> 9577404

Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease.

R Smith1.   

Abstract

Fibrodysplasia (myositis) ossificans progressiva is a rare dominantly inherited disorder, in which defects in skeletal patterning particularly affecting the big toes, are associated with progressive endochondral ossification of the large striated muscles in a specific order leading to prolonged disability. A recent series of 28 patients studied for as many as 24 years exemplifies the presentation and course of this disease. Painful swelling of muscles (myositis) leading to ossification began at a mean age of 4.6 years (range, 0-16 years) initially in the neck and upper spine (in 25 subjects) and later around the hips, other major joints, and jaw. The rate and extent of disability was unrelated to the time of onset. No form of treatment produced consistent benefit. Despite the unique clinical features, the initial diagnosis of fibrodysplasia ossificans progressiva was often wrong and usually considerably delayed. Mistaken histologic diagnoses such as soft tissue sarcoma or fibromatosis could lead to inappropriate treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9577404

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

Authors:  G Feldman; M Li; S Martin; M Urbanek; J A Urtizberea; M Fardeau; M LeMerrer; J M Connor; J Triffitt; R Smith; M Muenke; F S Kaplan; E M Shore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies.

Authors:  Hasan Ulusoy
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

3.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

4.  Nanogel-Mediated RNAi Against Runx2 and Osx Inhibits Osteogenic Differentiation in Constitutively Active BMPR1A Osteoblasts.

Authors:  Arun R Shrivats; Michael C McDermott; Molly Klimak; Saadyah E Averick; Haichun Pan; Krzysztof Matyjaszewski; Yuji Mishina; Jeffrey O Hollinger
Journal:  ACS Biomater Sci Eng       Date:  2015-09-25

5.  FOP: still turning into stone.

Authors:  Reza Taslimi; Saba Jafarpour; Nahid Hassanpour
Journal:  Clin Rheumatol       Date:  2013-11-20       Impact factor: 2.980

6.  The stone man disease: fibrodysplasia ossificans progressiva: imaging revisited.

Authors:  Amit Kumar Verma; Pallavi Aga; Shailesh Kumar Singh; Ragini Singh
Journal:  BMJ Case Rep       Date:  2012-07-25

Review 7.  Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP).

Authors:  Eileen M Shore; Frederick S Kaplan
Journal:  Bone       Date:  2008-05-28       Impact factor: 4.398

8.  Fibrodysplasia ossificans progressiva: three Indian patients with mutation in the ACVR1 gene.

Authors:  Anju Shukla; Onjal Taywade; Joshi Stephen; Divya Gupta; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2013-08-06       Impact factor: 1.967

Review 9.  Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Qi Shen; Vitali Lounev; Petra Seemann; Jay Groppe; Takenobu Katagiri; Robert J Pignolo; Eileen M Shore
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

10.  Biological activity of a genetically modified BMP-2 variant with inhibitory activity.

Authors:  Uwe Klammert; Joachim Nickel; Kristian Würzler; Christoph Klingelhöffer; Walter Sebald; Alexander C Kübler; Tobias Reuther
Journal:  Head Face Med       Date:  2009-02-02       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.